U.S. flag

An official website of the United States government

NM_000372.5(TYR):c.265T>C (p.Cys89Arg) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Sep 25, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000085941.5

Allele description [Variation Report for NM_000372.5(TYR):c.265T>C (p.Cys89Arg)]

NM_000372.5(TYR):c.265T>C (p.Cys89Arg)

Gene:
TYR:tyrosinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q14.3
Genomic location:
Preferred name:
NM_000372.5(TYR):c.265T>C (p.Cys89Arg)
HGVS:
  • NC_000011.10:g.89178218T>C
  • NG_008748.1:g.5347T>C
  • NM_000372.5:c.265T>CMANE SELECT
  • NP_000363.1:p.Cys89Arg
  • NC_000011.9:g.88911386T>C
  • NM_000372.4:c.265T>C
  • P14679:p.Cys89Arg
Protein change:
C89R; CYS89ARG
Links:
UniProtKB: P14679#VAR_007659; OMIM: 606933.0011; dbSNP: rs28940877
NCBI 1000 Genomes Browser:
rs28940877
Molecular consequence:
  • NM_000372.5:c.265T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000118084Retina International
no classification provided
not providednot providednot provided

SCV002235131Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 25, 2021)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Description

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providednot providednot providednot providednot providednot provided1not providedliterature only

Citations

PubMed

Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1).

Ghodsinejad Kalahroudi V, Kamalidehghan B, Arasteh Kani A, Aryani O, Tondar M, Ahmadipour F, Chung LY, Houshmand M.

PLoS One. 2014;9(9):e106656. doi: 10.1371/journal.pone.0106656.

PubMed [citation]
PMID:
25216246
PMCID:
PMC4162572

Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.

Spritz RA, Strunk KM, Hsieh CL, Sekhon GS, Francke U.

Am J Hum Genet. 1991 Feb;48(2):318-24.

PubMed [citation]
PMID:
1899321
PMCID:
PMC1683030
See all PubMed Citations (5)

Details of each submission

From Retina International, SCV000118084.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot providednot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1not providednot provided1not providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002235131.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Cys89 amino acid residue in TYR. Other variant(s) that disrupt this residue have been observed in individuals with TYR-related conditions (PMID: 25216246), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TYR protein function. ClinVar contains an entry for this variant (Variation ID: 3781). This missense change has been observed in individual(s) with oculocutaneous albinism (PMID: 1899321, 16517127, 27734839). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with arginine at codon 89 of the TYR protein (p.Cys89Arg). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and arginine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024